 SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 PRNewswire --IDEAYA Biosciences, Inc. NASDAQ: IDYA, a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced IDEAYAs inaugural Synthetic Lethality... 